Two appointments at TranScrip Partners
This article was originally published in Scrip
TranScrip Partners, a pharmaceutical development company that provides advice to pharmaceutical and biotech companies across a range of therapeutic areas, has appointed Julia Lloyd-Parks and Mark Watling as senior partners. Ms Lloyd-Parks has 30 years' clinical and drug development experience, having held clinical research posts in Novartis, Syntex and Innovex. Mr Watling is a senior pharmaceutical executive with 18 years' experience in clinical development, and has worked as medical director at Cephalon, head of medical partnership at Novo Nordisk and group medical director at Archimedes Pharma.